Phase I/II, Open-Label Trial of Three Monoclonal Antibodies

NCT00219986 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Potent HAART during acute or early HIV-1 infection

Sponsor

Rockefeller University